Literature DB >> 3785677

Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders.

A G Herzog.   

Abstract

We studied eight women who had complex partial seizures and anovulatory cycles or inadequate luteal phases. Progesterone suppositories were given during the premenstrual phase or entire second half of the cycle in doses of 50 to 400 mg q12h. Antiseizure medication levels were kept in the therapeutic range. Average monthly seizure frequency declined by 68% (p less than 0.05, Wilcoxon matched-pairs test) in a 3-month treatment period compared with the 3 months prior to therapy, and six of the eight women had fewer seizures. None experienced more seizures or disruption of menses. Transient tiredness and depression were noted in some when progesterone dosage was raised above minimally effective levels. These symptoms cleared within 48 hours of lowering the dosage. The value of intermittent natural progesterone therapy as a safe, well-tolerated, and effective adjunct to antiseizure therapy should be assessed further.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3785677     DOI: 10.1212/wnl.36.12.1607

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 2.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

3.  Variation of seizure frequency with ovulatory status of menstrual cycles.

Authors:  Andrew G Herzog; Kristen M Fowler; Michael R Sperling; Joyce D Liporace; Laura A Kalayjian; Christianne N Heck; Gregory L Krauss; Barbara A Dworetzky; Page B Pennell
Journal:  Epilepsia       Date:  2011-07-14       Impact factor: 5.864

4.  Treatment of catamenial epilepsy is still up in the air.

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

5.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

Review 6.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

Review 7.  Influence of sex hormones on brain excitability and epilepsy.

Authors:  A Verrotti; G Latini; R Manco; M De Simone; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

Review 8.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 9.  A Treatment Approach to Catamenial Epilepsy.

Authors:  Allison Navis; Cynthia Harden
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

10.  The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients.

Authors:  J Bauer; L Wildt; D Flügel; H Stefan
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.